Plant Comparison
Meadowsweet vs Goldenrod
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Meadowsweet and Goldenrod: they share 7 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Meadowsweet | Goldenrod | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Swelling / fluid retention | 1/10 | 1/10 | Comparable evidence |
| Urinary support | 1/10 | 7/10 | Stronger for Goldenrod |
| Urinary tract infection (UTI) | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.
Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.
Contribute to astringency and the characteristic sweet almond-like fragrance.
Pharmacological Actions
Traditional & Indicated Uses
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
Safety, Cautions & Contraindications
Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.
Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).
Generally well tolerated. Not recommended in cases of fluid retention due to impaired cardiac or renal function. Ensure adequate fluid intake when using as a diuretic. May cause allergic reactions in individuals sensitive to Asteraceae plants. Avoid use during pregnancy and breastfeeding due to limited safety data.
Duke (2002) provides clinical evidence (score 2) for goldenrod's anti-inflammatory activity, consistent with Commission E approval. It is also classified as an aquaretic (increases urine output without electrolyte loss) and antispasmodic, used for urinary tract irrigation therapy. Dose: 6–12 g dried herb daily as tea for urinary complaints. Duke cautions against use in cases of edema from renal or cardiac insufficiency, and notes that the herb may cause allergic reactions in individuals sensitive to Asteraceae plants (Duke, 2002).
External Ids
Botanical Description
Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]
Perennial herb (Asteraceae), 20-100 cm tall, with erect, often reddish, downy or smooth stems. Leaves are alternate, lance-shaped and toothed. Numerous small, bright yellow, daisy-like flower heads are clustered into branched, plume-like terminal sprays, followed by small ribbed achenes with a tuft of hairs (pappus).[1]
Habitat
Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]
Harvesting
The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]
The flowering aerial parts are cut during flowering (late summer) and dried.[11]
Traditional Uses
Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]
Goldenrod has a long European folk-medicine tradition as a mild 'aquaretic' diuretic and anti-inflammatory remedy for the urinary tract, used traditionally for urinary-tract irrigation therapy alongside adequate fluid intake, and topically as a wound herb (one common name is 'woundwort'). Modern phytochemical work confirms saponin- and flavonoid-driven anti-inflammatory, antioxidant and diuretic activity.[1, 11]
Preparations
Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.
Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.
Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.
Dried aerial parts steeped in hot water - the classic urinary-tract preparation.
Dosage
The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
https://doi.org/10.1016/j.jep.2017.11.013 - Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
https://doi.org/10.3390/antiox13101200 - Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
https://doi.org/10.3390/pharmaceutics15041291 - Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
https://doi.org/10.1016/j.jep.2016.10.015 - Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
https://doi.org/10.1016/j.jep.2016.10.024 - Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
https://doi.org/10.1016/j.fct.2016.11.018 - Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
https://doi.org/10.31083/j.jin2004089 - Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
https://doi.org/10.1016/j.jep.2015.08.025 - Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
https://doi.org/10.3390/molecules28176349 - Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
https://doi.org/10.1055/s-2006-962390 - Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
https://doi.org/10.1055/a-1647-2866 - Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
https://doi.org/10.1080/09553002.2016.1257834 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf - Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook - Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Fursenco, C., Calalb, T., Uncu, L., Dinu, M. and others (2020) 'Solidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities', Biomolecules, 10(12), pp. 1619. doi:10.3390/biom10121619 Meta-analysis / review
https://doi.org/10.3390/biom10121619 - Abdel Motaal, A., Ezzat, S.M., Tadros, M.G. and El-Askary, H.I (2016) 'In vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats', Pharmaceutical Biology, 54(12), pp. 2864-2870. doi:10.1080/13880209.2016.1190381 Preclinical
https://doi.org/10.1080/13880209.2016.1190381 - Précheur, I., Rolland, Y., Hasseine, L., Orange, F. and others (2020) 'Solidago virgaurea L. Plant Extract Targeted Against Candida albicans to Reduce Oral Microbial Biomass: A Double Blind Randomized Trial on Healthy Adults', Antibiotics, 9(4), pp. 137. doi:10.3390/antibiotics9040137 Randomized trial
https://doi.org/10.3390/antibiotics9040137 - Wojnicz, D., Tichaczek-Goska, D., Glensk, M. and Hendrich, A.B (2021) 'Is It Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli Rods? An In Vitro Model Study', Pharmaceutics, 13(4), pp. 573. doi:10.3390/pharmaceutics13040573 Preclinical
https://doi.org/10.3390/pharmaceutics13040573 - El-Tantawy, W.H (2013) 'Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity', Journal of Physiology and Biochemistry, 70(1), pp. 33-42. doi:10.1007/s13105-013-0277-0 Preclinical
https://doi.org/10.1007/s13105-013-0277-0 - Gross, S.C., Goodarzi, G., Watabe, M., Bandyopadhyay, S. and others (2002) 'Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model', Nutrition and Cancer, 43(1), pp. 76-81. doi:10.1207/S15327914NC431_9 Preclinical
https://doi.org/10.1207/S15327914NC431_9 - Starks, C.M., Williams, R.B., Goering, M.G., O'Neil-Johnson, M. and others (2010) 'Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea)', Phytochemistry, 71(1), pp. 104-109. doi:10.1016/j.phytochem.2009.09.032 Preclinical
https://doi.org/10.1016/j.phytochem.2009.09.032 - Malicanin, M., Karabegovic, I., Dordevic, N., Mancic, S. and others (2024) 'Influence of the Extraction Method on the Biological Potential of Solidago virgaurea L. Essential Oil and Hydrolates', Plants, 13(16), pp. 2187. doi:10.3390/plants13162187 Preclinical
https://doi.org/10.3390/plants13162187 - Zehra, S.A., Bhattarai, P., Zhang, J., Liu, Y. and others (2022) 'Phytochemical Analysis and Evaluation of the Antidiabetic Activity of Solidago virgaurea Extracts', Current Bioactive Compounds, 19(4), pp. e150622206146. doi:10.2174/1573407218666220615143502 Preclinical
https://doi.org/10.2174/1573407218666220615143502 - Jang, Y.S., Wang, Z., Lee, J.M., Lee, J.Y. and others (2016) 'Screening of Korean Natural Products for Anti-Adipogenesis Properties and Isolation of Kaempferol-3-O-rutinoside as a Potent Anti-Adipogenetic Compound from Solidago virgaurea', Molecules, 21(2), pp. 226. doi:10.3390/molecules21020226 Preclinical
https://doi.org/10.3390/molecules21020226 - European Medicines Agency (2008) 'Community herbal monograph on Solidago virgaurea L., herba'. Traditional / reference
https://scholar.google.com/scholar?q=Community%20herbal%20monograph%20on%20Solidago%20virgaurea%20L.%2C%20herba - Bader, G., Binder, K., Hiller, K. and Zwintscher, U (1990) 'The saponins from Solidago virgaurea L', 45(8), pp. 618--622. Traditional / reference
https://scholar.google.com/scholar?q=The%20saponins%20from%20Solidago%20virgaurea%20L - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Grow Forage Cook Ferment 'Foraging Goldenrod (Solidago): Identification and Uses'. Available at: https://www.growforagecookferment.com/foraging-goldenrod/ Traditional / reference
https://www.growforagecookferment.com/foraging-goldenrod/ - Washington State Noxious Weed Control Board 'Tansy Ragwort (Senecio jacobaea)'. Available at: https://www.nwcb.wa.gov/weeds/tansy-ragwort Traditional / reference
https://www.nwcb.wa.gov/weeds/tansy-ragwort - Schneider, J. and Tsegaye, Y. and W/Tensae, M. and G/Selassie, S. and Haile, T. and Bane, A. and Ali, A. and Mesfin, G. and Seboxa, T (2012) 'Veno-occlusive liver disease: a case report', Ethiopian Medical Journal, 50 Suppl 2, pp. 47-51. Available at: https://pubmed.ncbi.nlm.nih.gov/22946295/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22946295/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.